Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martina Bortolot

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Cancer Treatment Reviews|July 7, 2024
Treatment of unresectable stage III non-small cell lung cancer for patients who are under-represented in clinical trialsMartina Bortolot, Francesco Cortiula, Gianpiero Fasola, et al.
Cancers|June 19, 2024
Targeted Therapy in Mesotheliomas: Uphill All the WayElisa Bertoli, Elisa De Carlo, Martina Bortolot, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 8, 2026
Less Is More, But Me-Too Should Not Be the Strategy for Lung Cancer Treatment in 2026Martina Bortolot, Stephanie P L Saw, Erica Pietroluongo, et al.
International Journal of Molecular Sciences|December 17, 2024
Navigating Therapeutic Challenges in BRAF-Mutated NSCLC: Non-V600 Mutations, Immunotherapy, and Overcoming ResistanceMartina Bortolot, Sara Torresan, Elisa De Carlo, et al.
Cancers|May 14, 2025
Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor (EGFR) Common Mutations: New StrategiesBrigida Stanzione, Alessandro Del Conte, Elisa Bertoli, et al.
International Journal of Molecular Sciences|January 25, 2025
Matters of the Heart: Cardiotoxicity Related to Target Therapy in Oncogene-Addicted Non-Small Cell Lung CancerSara Torresan, Martina Bortolot, Elisa De Carlo, et al.
International Journal of Molecular Sciences|July 9, 2022
Immunotherapy in NSCLC Patients with Brain MetastasesSilvia Buriolla, Giacomo Pelizzari, Carla Corvaja, et al.
JAMA Oncology|September 4, 2025
Current Controversies and Challenges in Non-Oncogene-Addicted Synchronous Oligometastatic Non-Small Cell Lung Cancer: A ReviewMandy Jongbloed, Martina Bortolot, Jonas Willmann, et al.
Cancers|August 29, 2024
Early-Stage Non-Small Cell Lung Cancer: New Challenges with Immune Checkpoint Blockers and Targeted TherapiesPernelle Lavaud, Martina Bortolot, Lodovica Zullo, et al.
Critical Reviews in Oncology/Hematology|December 21, 2023
Liquid biopsy in colorectal cancer: Onward and upwardSara Torresan, Marco de Scordilli, Martina Bortolot, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Cancer Treatment Reviews|July 7, 2024
Treatment of unresectable stage III non-small cell lung cancer for patients who are under-represented in clinical trialsMartina Bortolot, Francesco Cortiula, Gianpiero Fasola, et al.
Cancers|June 19, 2024
Targeted Therapy in Mesotheliomas: Uphill All the WayElisa Bertoli, Elisa De Carlo, Martina Bortolot, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 8, 2026
Less Is More, But Me-Too Should Not Be the Strategy for Lung Cancer Treatment in 2026Martina Bortolot, Stephanie P L Saw, Erica Pietroluongo, et al.
International Journal of Molecular Sciences|December 17, 2024
Navigating Therapeutic Challenges in BRAF-Mutated NSCLC: Non-V600 Mutations, Immunotherapy, and Overcoming ResistanceMartina Bortolot, Sara Torresan, Elisa De Carlo, et al.
Cancers|May 14, 2025
Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor (EGFR) Common Mutations: New StrategiesBrigida Stanzione, Alessandro Del Conte, Elisa Bertoli, et al.
International Journal of Molecular Sciences|January 25, 2025
Matters of the Heart: Cardiotoxicity Related to Target Therapy in Oncogene-Addicted Non-Small Cell Lung CancerSara Torresan, Martina Bortolot, Elisa De Carlo, et al.
International Journal of Molecular Sciences|July 9, 2022
Immunotherapy in NSCLC Patients with Brain MetastasesSilvia Buriolla, Giacomo Pelizzari, Carla Corvaja, et al.
JAMA Oncology|September 4, 2025
Current Controversies and Challenges in Non-Oncogene-Addicted Synchronous Oligometastatic Non-Small Cell Lung Cancer: A ReviewMandy Jongbloed, Martina Bortolot, Jonas Willmann, et al.
Cancers|August 29, 2024
Early-Stage Non-Small Cell Lung Cancer: New Challenges with Immune Checkpoint Blockers and Targeted TherapiesPernelle Lavaud, Martina Bortolot, Lodovica Zullo, et al.
Critical Reviews in Oncology/Hematology|December 21, 2023
Liquid biopsy in colorectal cancer: Onward and upwardSara Torresan, Marco de Scordilli, Martina Bortolot, et al.
Pageof 3